Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1962
Last updated 2019-11-26
Summary
Faced with high rates of immunization drop-out, Uganda's immunization program requires innovative approaches to address this weakness. Building upon Uganda's growing mHealth infrastructure to pilot a scalable short message service (SMS) system to remind caregivers of their children's upcoming vaccination visits, it was hypothesized that the SMS intervention will increase immunization coverage in a cost-effective and affordable manner that would make it scalable. The study design was an investigator-blinded, multi-center, parallel groups randomized controlled trial with randomization occurring at the caregiver level in select health facilities of Arua District in Uganda. Enrollment took place at the time of Pentavalent 1 vaccination, and both arms included standard of care provided by the health worker. However, in the intervention arm, caregivers also received SMS text messages reminding them to return for their children's second and third doses of Pentavalent vaccine (four and eight weeks after the first dose of Pentavalent vaccine) and measles-containing vaccine (9 months of age). The primary outcome of interest is vaccination coverage at 12 months of age among children enrolled in the study and will be measured by comparing Penta3 and MCV coverage between arms. The study will also examine the SMS impact on timeliness of vaccine receipt, as it is hypothesized that those children receiving the SMS intervention will be more likely to have timely vaccination than those in the control group. The study will also assess caregiver acceptability and cost-effectiveness of the SMS intervention. In addition to assessing its impact on strengthening the immunization program, this intervention has implications for strengthening other programs of the health system through similar health messaging directed toward caregivers.
Conditions
- Diphtheria
- Tetanus
- Pertussis
- Polio
- Measles
- Hepatitis B
- Haemophilus Influenzae Type b Infection
Interventions
- BEHAVIORAL
-
SMS text reminders
SMS reminders (in English and the local language) for the 2nd dose of Pentavalent vaccine were sent 28, 30 and 32 days after the 1st dose. SMS reminders for the 3rd dose of Pentavalent vaccine were sent 61, 66, and 68 days after the 1st dose. SMS reminders for the measles-containing vaccine were sent 274, 279, and 281 days after the child's date of birth.
Sponsors & Collaborators
-
African Field Epidemiology Network
collaborator UNKNOWN -
Ministry of Health, Uganda
collaborator OTHER_GOV -
Health Information Systems Programme-Uganda
collaborator UNKNOWN -
Bill and Melinda Gates Foundation
collaborator OTHER -
Centers for Disease Control and Prevention
lead FED
Principal Investigators
-
Daniel C Ehlman, MPH · Centers for Disease Control and Prevention
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-01
- Primary Completion
- 2017-12-04
- Completion
- 2017-12-04
More Related Trials
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3
-
mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau
NCT02662595 ·Status: UNKNOWN ·Phase: NA
-
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
NCT01830257 ·Status: UNKNOWN ·Phase: PHASE4
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan
NCT03341195 ·Status: UNKNOWN ·Phase: NA
-
Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.
NCT01668745 ·Status: COMPLETED ·Phase: PHASE4
-
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
NCT06667206 ·Status: RECRUITING ·Phase: PHASE2
-
SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan
NCT01859546 ·Status: UNKNOWN ·Phase: NA
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT06762938 ·Status: COMPLETED ·Phase: NA
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
NCT02378207 ·Status: COMPLETED ·Phase: PHASE1
-
Prophylactic Antibiotics in Measles
NCT00168532 ·Status: COMPLETED ·Phase: PHASE3
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents
NCT02075203 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Assess the Safety of a Measles Vaccine (Dry Powder) Administered by Two Different Devices
NCT01557699 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
NCT06616753 ·Status: RECRUITING
-
Trial of Additional Measles Vaccine to Reduce Child Mortality
NCT01644721 ·Status: COMPLETED ·Phase: PHASE4
-
The Interaction Between Measles and DTP Vaccination
NCT02710045 ·Status: COMPLETED ·Phase: NA
-
Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children
NCT03460002 ·Status: COMPLETED ·Phase: PHASE4
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1